Identifying specific causes of kidney allograft loss

American Journal of Transplantation

Volumn 9, Issue 3, 2009, Pages 527-535

  El Zoghby, Z M ^a   Stegall, M D ^b   Lager, D J ^b   Kremers, W K ^b   Amer, H ^a   Gloor, J M ^a   Cosio, F G ^a  

^a William von Liebig Transplant Center   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; CADAVER KIDNEY; FEMALE; GLOMERULOPATHY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR;

ACUTE DISEASE; ATROPHY; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 60649101659     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02519.x     Document Type: Article

References (31)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004 4 : 378 383.
2. 2007 Annual Data Report. Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 2008 51 : S1 S319.
3. Gill JS, Rose C, Pereira BJ, Tonelli M. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007 71 : 442 447.
4. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetes. Am J Transplant 2008 8 : 593 599.
5. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002 347 : 103 109.
6. Matas AJ. Recurrent disease after kidney transplantation-it is time to unite to address this problem Am J Transplant 2006 6 : 2527 2528.
7. Hariharan S, Adams M, Brennan D et al. Recurrent and De Novo Glomerular Disease after Renal Transplantation. Transplantation 1999 68 : 635 641.
8. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007 18 : 1046 1056.
9. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007 7 : 1743 1752.
10. Gloor JM, Sethi S, Stegall MD et al. Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody. Am J Transplant 2007 9 : 2124 2132.
11. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: A prospective trial. Am J Transplant 2004 4 : 438 443.
12. Schweitzer EJ, Matas AJ, Gillingham KJ et al. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 1991 214 : 679 688.
13. Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990s: A single-center analysis. Kidney Int 2002 62 : 704 714.
14. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993 44 : 411 422.
15. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526.
16. Halloran PF. Call for revolution: A new approach to describing allograft deterioration. Am J Transplant 2002 2 : 195 200.
17. Cosio FG, Grande JP, Larson TS et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005 5 : 1130 1136.
18. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
19. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
20. Cosio FG, Amer H, Grande JP, Larson TS, Stegall MD, Griffin MD. Comparison of low versus high tacrolimus levels in kidney transplantation: Assessment of efficacy by protocol biopsies. Transplantation 2007 83 : 411 416.
21. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999 18 : 695 706.
22. Cosio FG, Gloor JM, Sethi S, Stegall MD. Transplant glomerulopathy. Am J Transplant 2008 8 : 492 496.
23. Amer H, Fidler ME, Myslak M et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 2007 7 : 2748 2756.
24. Glassock RJ, Feldman D, Reynolds ES, Dammin GJ, Merrill JP. Human renal isografts: A clinical and pathologic analysis. Medicine (Baltimore) 1968 47 : 411 454.
25. Dabade TS, Grande JP, Norby SM, Fervenza FC, Cosio FG. Recurrent idiopathic membranous nephropathy after kidney transplantation: A surveillance biopsy study. Am J Transplant 2008.
26. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326 2333.
27. Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004 4 : 1776 1785.
28. Khamash HA, Wadei HM, Mahale AS et al. Polyomavirus-associated nephropathy risk in kidney transplants: The influence of recipient age and donor gender. Kidney Int 2007 71 : 1302 1309.
29. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 1999 10 : 167 181.
30. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003 75 : 1291 1295.
31. Segoloni GP, Messina M, Giraudi R et al. Renal transplantation in patients over 65 years of age: No more a contraindication but a growing indication. Transplant Proc 2005 37 : 721 725.